SEC declares Nexalin S-1 effective covering up to 2.8M shares from warrant exercises

Nexalin Technology, Inc.

Registration statement effective for up to 2,798,613 shares of common stock.
Includes 347,250 shares from Maxim Partners warrant (2022 IPO), 2,315,000 from public offering warrants, and 136,363 shares to Maxim as compensation.
All warrants exercisable at $4.15 per share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.